.
home.aspx
   

Webinars

Using a Learning Management System (LMS) to Develop Pharma Training Curricula
USING A LEARNING MANAGEMENT SYSTEM (LMS) TO DEVELOP PHARMA TRAINING CURRICULA
June 27-27, 2019
Learning Management Systems (LMSs) are important tools for assuring and demonstrating that Pharma employees maintain their training, and their GMP compliance, up to date. They often boast great functionality but also have limitations that must be overcome for a Pharma company to use them effectively...

Efficient Handling of Chemical Raw Materials in Biopharmaceutical Manufacturing
EFFICIENT HANDLING OF CHEMICAL RAW MATERIALS IN BIOPHARMACEUTICAL MANUFACTURING
June 27-27, 2019
Chemical raw materials are used in multi-tons per batch during biopharmaceutical manufacturing. Managing such quantities in a pharmaceutical production environment can be challenging: Handling and weighing procedures can be time-consuming and costly. In addition, the formation of dust and caking/clu...

PHARMACEUTICAL CHALLENGES IN CHINA
PHARMACEUTICAL CHALLENGES IN CHINA
June 27-27, 2019
China has become one of the world’s foremost drivers for global production and demand (6.6 per cent GDP increase in 2018). With more available income and an ageing population the demand on public health products and services in the country is booming. However, this growing market is also targe...

ICH Q10, The Pharmaceutical Quality System – Bring The Pharmaceutical Industry Into The 20st Century
ICH Q10, THE PHARMACEUTICAL QUALITY SYSTEM – BRING THE PHARMACEUTICAL INDUSTRY INTO THE 20ST CENTURY
June 28-28, 2019
ICH Q10 describes one comprehensive model for an effective pharmaceutical quality system that is based on International Standards Organisation (ISO) quality concepts, includes applicable Good Manufacturing Practice (GMP) regulations and complements ICH Q8 “Pharmaceutical Development” and...

CHEMICAL AND PHYSICAL TRANSFORMATION MONITORING
CHEMICAL AND PHYSICAL TRANSFORMATION MONITORING
July 01-01, 2019
During the lengthy process of pharmaceutical development, an Active Pharmaceutical Ingredient (API) or its intermediates can go through many physical and chemical changes. These changes are needed to produce the API with the correct chemical structure and physical property. Monitoring the progress o...

CHEMICAL AND PHYSICAL TRANSFORMATION MONITORING BY RAMAN AND IR SPECTROSCOPIES IN PHARMACEUTICAL DEVELOPMENT
CHEMICAL AND PHYSICAL TRANSFORMATION MONITORING BY RAMAN AND IR SPECTROSCOPIES IN PHARMACEUTICAL DEVELOPMENT
July 01-01, 2019
During the lengthy process of pharmaceutical development, an Active Pharmaceutical Ingredient (API) or its intermediates can go through many physical and chemical changes. These changes are needed to produce the API with the correct chemical structure and physical property. Monitoring the progress o...

The key drivers to IIoT technology adoption in the pharmaceutical manufacturing sector
THE KEY DRIVERS TO IIOT TECHNOLOGY ADOPTION IN THE PHARMACEUTICAL MANUFACTURING SECTOR
July 03-03, 2019
The pharmaceutical sector is one of the most highly regulated industries facing increased market pressure and high R&D costs. Ensuring regulatory compliance, maintaining product quality whilst improving efficiency of operations are all top priorities. Join Fraser Thomson, Business Development Di...

Strategies to Combat Counterfeit Drugs and Other Supply Chain Threats
STRATEGIES TO COMBAT COUNTERFEIT DRUGS AND OTHER SUPPLY CHAIN THREATS
July 03-03, 2019
This webinar is designed to provide an overview of the problem of counterfeit drugs and suggest ways to combat it, some that have been employed for years and others that have been developed more recently. The challenge in preventing counterfeit drugs from infiltrating the supply chain is to make it ...

The key drivers to IIoT technology adoption in the pharmaceutical manufacturing sector
THE KEY DRIVERS TO IIOT TECHNOLOGY ADOPTION IN THE PHARMACEUTICAL MANUFACTURING SECTOR
July 03-03, 2019
The pharmaceutical sector is one of the most highly regulated industries facing increased market pressure and high R&D costs. Ensuring regulatory compliance, maintaining product quality whilst improving efficiency of operations are all top priorities. Join Fraser Thomson, Business Development Di...

Latest FDA EMA & Other Regulatory Requirements of Pharmaceutical Manufacturing
LATEST FDA EMA & OTHER REGULATORY REQUIREMENTS OF PHARMACEUTICAL MANUFACTURING
July 09-09, 2019
This instructor-led live training webinar will focus on the areas of production from manufacture of bulk drugs all the way to finished product including the packaging and labeling activities. While these areas are characterized by an incredibly diverse set of operations encompassing a wide range of ...

FDA EMA & Other Regulatory Requirements of Pharmaceutical Manufacturing
FDA EMA & OTHER REGULATORY REQUIREMENTS OF PHARMACEUTICAL MANUFACTURING
July 09-09, 2019
In this live training webinar, we will describe the basic principles used to prevent contamination, degradation and assure control of our processes, and hence products. We will walk through the major steps in the process (bulk and drug product manufacture, and packaging and labeling steps) to explai...

Latest FDA EMA & Other Regulatory Requirements of Pharmaceutical Manufacturing
LATEST FDA EMA & OTHER REGULATORY REQUIREMENTS OF PHARMACEUTICAL MANUFACTURING
July 09-09, 2019
In this live training webinar, we will describe the basic principles used to prevent contamination, degradation and assure control of our processes, and hence products. We will walk through the major steps in the process (bulk and drug product manufacture, and packaging and labeling steps) to explai...

Pharmaceutical Contamination of Food: Ensuring Food Safety and Complying with the Law
PHARMACEUTICAL CONTAMINATION OF FOOD: ENSURING FOOD SAFETY AND COMPLYING WITH THE LAW
July 09-09, 2019
This initial review will help food safety, quality, processor, buyer, compliance and other food supply chain members to begin to investigate the impact of pharmaceutical contamination in the foods they purchase, process, import and sell. We will also cover traceability issues critical to the appropr...

Toxic Impurities in Active Pharmaceutical Ingredients
TOXIC IMPURITIES IN ACTIVE PHARMACEUTICAL INGREDIENTS
July 10-10, 2019
The recent recalls of sartan antihypertensives due to the presence of nitrosamines may suggest increased attention from FDA to toxic impurities in drug products from active pharmaceutical ingredients. The public information about the limits of toxic impurities and about nitrosamines in sartans will ...

Are you ready to build the Biopharma Facility of the Future?
ARE YOU READY TO BUILD THE BIOPHARMA FACILITY OF THE FUTURE?
July 18-18, 2019
In recent years, we have been seeing a shift by the industry towards the production of more personalised medicines. To achieve this manufacturers across the biopharma industry are exploring highly flexible and scalable facilities utilising single use technologies.

Best Practices For Effective Pharma Technology Transfer: From R&D To Clinical To Commercial
BEST PRACTICES FOR EFFECTIVE PHARMA TECHNOLOGY TRANSFER: FROM R&D TO CLINICAL TO COMMERCIAL
July 18-18, 2019
This webinar discusses effective Pharmaceutical Technology Transfer procedures as they are currently practiced by successful pharmaceutical and biopharmaceutical firms. It introduces a compliant modular approach to technology transfer projects that cover multiple disciplines including Project Manage...

Optimization of a Pharmaceutical Granulation Process using Quality by Design (QbD)
OPTIMIZATION OF A PHARMACEUTICAL GRANULATION PROCESS USING QUALITY BY DESIGN (QBD)
July 19-19, 2019
Andy Tallevi is a Formulation/Process Consultant for Keller Consulting in Mississauga, Ont., Canada. He has 28 years of industrial experience, primarily in the Pharmaceutical industry. He currently consults clients in the Pharma and chemical industries assisting them with formulation and process iss...

How pharma marketing can stay ahead of the evolving customer journey
HOW PHARMA MARKETING CAN STAY AHEAD OF THE EVOLVING CUSTOMER JOURNEY
July 23-23, 2019
Customer journeys in pharma are changing, with important implications for the marketing supply chain. How can pharmaceutical marketers capitalise on this trend and free up budget to invest in additional marketing channels?

Designing an End-to-End Sterility Assurance Program
DESIGNING AN END-TO-END STERILITY ASSURANCE PROGRAM
July 25-25, 2019
Sterility assurance for a pharmaceutical product is critical, and includes many aspects outside of the actual sterilization cycle or aseptic process. There is some recent movement in the health care industry regarding the term End-to-End Sterility Assurance, along with a document being written throu...

GMP Data Integrity Best Practices and Regulatory Expectations for the Pharmaceutical Industry
GMP DATA INTEGRITY BEST PRACTICES AND REGULATORY EXPECTATIONS FOR THE PHARMACEUTICAL INDUSTRY
July 25-25, 2019
Data integrity is the cornerstone of your operations and the trusting relationship you have with your customers – the agencies and patients. This is true in the development cycle and submissions as well as in the manufacturing phases of the product lifecycle. Lapses in data integrity can hit a...

DESIGNING PRODUCTION FACILITIES OF THE FUTURE
DESIGNING PRODUCTION FACILITIES OF THE FUTURE
July 30-30, 2019
How can facilities be produced to meet the potential demand of cell and viral vectors? What needs to change and what innovations are being made

LIFECYCLE MANAGEMENT OF SINGLE USE TECHNOLOGIES
LIFECYCLE MANAGEMENT OF SINGLE USE TECHNOLOGIES
August 05-05, 2019
Single-use technologies (SUTs) are one of the key drivers in the biopharmaceutical industry today and are changing the way we are operating and qualifying our bioprocesses, offering more flexibility and increasing efficiency. However, the extended use of those technologies in commercial operations r...

Essentials of European Pharmaceutical Regulatory Affairs
ESSENTIALS OF EUROPEAN PHARMACEUTICAL REGULATORY AFFAIRS
August 05-05, 2019
This popular course provides an opportunity that on-the-job learning doesn't: network and learn from a variety of experts, including your fellow delegates.

A Guide to Updating HPLC Compendial Methods in Pharmaceutical Analysis
A GUIDE TO UPDATING HPLC COMPENDIAL METHODS IN PHARMACEUTICAL ANALYSIS
August 06-06, 2019
Separation Science, in collaboration with Agilent, offers an upcoming webinar that will discuss how changes to compendial method, known as adjustments, are made for HPLC separations and how these adjustments can be made with or without validation.

Monitoring Impurities in Pharmaceutical Products to Meet FDA and ICH Q3 A/B Requirements
MONITORING IMPURITIES IN PHARMACEUTICAL PRODUCTS TO MEET FDA AND ICH Q3 A/B REQUIREMENTS
August 14-14, 2019
Monitoring impurities is considered a critical activity of analytical development in order to ensure the quality of the pharmaceutical products. Current ICH Guidelines indicate that the measurement of impurities should always be conducted for active pharmaceutical ingredient (API) and its drug produ...

Forensics and Toxicology 2019
FORENSICS AND TOXICOLOGY 2019
August 22-22, 2019
LabRoots is pleased to announce a new addition to our virtual conference line up for 2019, Forensics/Toxicology! The exciting field of Forensics/Toxicology is focused on a blend of biology, chemistry, pharmacology, and medicine, that involves the study of the adverse effects of chemical substances o...

Alternative And Rapid Microbiological Methods: Microbiology Of The 21st Century
ALTERNATIVE AND RAPID MICROBIOLOGICAL METHODS: MICROBIOLOGY OF THE 21ST CENTURY
September 12-08, 2019
Today Pharmaceutical industry remains conservative for microbiology testing methods and his reluctance to develop and to use Alternative and Rapid Microbiological Methods (RMM) supported by a number of misunderstandings and prejudgments based on the following myths: RMM is not accepted by regulation...

Pharmaceutical Contamination And Food Safety
PHARMACEUTICAL CONTAMINATION AND FOOD SAFETY
September 17-17, 2019
What foods have drugs in them?  How do the drugs get there? What impact can these foods have on humans?  What impact can recall of pharmaceutically contaminated foods have on your business? Processors, packers, distributors and other food supply chain members need to know which foods are b...

CDISC Mapping 5: ADAM Models - ADSL, BDS and ADAE
CDISC MAPPING 5: ADAM MODELS - ADSL, BDS AND ADAE
September 18-18, 2019
CDISC requirements to create SDTMs and ADAMs are not easy to understand or apply. There are many rules and standards that must be mastered and maintained across global studies. Pharmaceutical companies and CROs supporting global studies have a need to apply proven methods that reduce confusion and i...

CRISPR 2019
CRISPR 2019
October 03-03, 2019
LabRoots invites you to the 2nd Annual CRISPR Virtual Event! This follows up event to a very popular first-year event will continue the conversation of the abilities of CRISPR-based editing, next-gen editing tools, precision in gene editing and using CRISPR for drug discovery. This event will bring ...

Elemental Impurities Compliance for the Pharmaceutical Industry
ELEMENTAL IMPURITIES COMPLIANCE FOR THE PHARMACEUTICAL INDUSTRY
October 08-08, 2019
The subject is of importance to the manufacturers of new drug products as they are required to comply with the new elemental impurities standards either through risk assessments or through testing as new regulatory submissions are made, and to manufacturers of existing products as they make decision...

ENGINEERING FIRST PRINCIPLES: APPLICATIONS TO PHARMACEUTICAL MANUFACTURING
ENGINEERING FIRST PRINCIPLES: APPLICATIONS TO PHARMACEUTICAL MANUFACTURING
November 05-05, 2019
Within the pharmaceutical industry, creating a robust Operational Control Strategy (OCS) is a key step to accomplishing the goals of Quality by Design (QbD). Along the way to developing this robust Operational Control Strategy many problems will be encountered that need to be solved.

ICH Q12 - New approach to support innovation
ICH Q12 - NEW APPROACH TO SUPPORT INNOVATION
November 05-05, 2019
Progress has been made towards developing the new ICH Q12 Guideline on Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management.

Influenza 2019
INFLUENZA 2019
November 06-06, 2019
This virtual, online conference will provide a single day packed with speaker sessions with industry experts, research poster presentations, and an exhibit hall with thought leaders from the field. Influenza 2019 is the perfect platform for leading scientists, researchers, practitioners, public heal...

Clinical Diagnostics & Research 2019
CLINICAL DIAGNOSTICS & RESEARCH 2019
November 14-14, 2019
On November 14th thousands of will join in a discussion of the continuous progress made with advances in laboratory testing and patient care and treatment. With new technologies and treatments available, updates in regulatory processes are also necessary to ensure patient safety and proper practices...

The role of immune cells and immune checkpoints in multiple myeloma
THE ROLE OF IMMUNE CELLS AND IMMUNE CHECKPOINTS IN MULTIPLE MYELOMA
November 21-21, 2019
Multiple Myeloma is a disease of terminally differentiated plasma cells with the massive production of monoclonal immunoglobulins in the bone marrow. Today there are many treatment modalities ongoing targeting the myeloma microenvironment, but especially immunotherapy seems to be a promising approac...

Utility of Generating Data: Drug Manufacture Perspective
UTILITY OF GENERATING DATA: DRUG MANUFACTURE PERSPECTIVE
January 21-21, 2020
Ken Wong is a Deputy Director of Process Technology Platform at Sanofi Pasteur. Serving as the Swiftwater site extractables and leachables (E&L) SME but also provide E&L supports to all global sites. His 19-year in biopharma professional career has ranged from R&D to development and comm...

UTILITY OF GENERATING <665> DATA: DRUG MANUFACTURE’S PERSPECTIVE: WILL USP PERMIT SUCH FORMAT?
UTILITY OF GENERATING <665> DATA: DRUG MANUFACTURE’S PERSPECTIVE: WILL USP PERMIT SUCH FORMAT?
January 21-21, 2020
Integrating Data in Drug Manufacturing, How Data and the Internet of Things Will Impact and Optimize Process. Integrating data from the drug development phase through drug manufacturing presents an additional set of challenges. As with drug development, the infrastructure needed to manage the data i...

HIGH-RESOLUTION CHARACTERIZATION OF STRUCTURE, INTERACTION, AND MISCIBILITY OF DRUG PRODUCTS
HIGH-RESOLUTION CHARACTERIZATION OF STRUCTURE, INTERACTION, AND MISCIBILITY OF DRUG PRODUCTS
February 11-11, 2020
The local interactions between a drug and its surrounding environment is critical in both small and large molecule formulations. For small molecules, the drug-polymer interaction is needed to ensure that the drug does not crystallize in an amorphous solid dispersion. For proteins, phase separation i...

SPOTLIGHT

Over the past few years, neuroscientists have been able to grow ever larger and more complex spheroid cultures and organoids that replicate the structure and functionality of brain tissue. While these...